praziquantel has been researched along with Nervous System Diseases in 19 studies
azinox: Russian drug
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Praziquantel (PZQ) is the drug of choice in the treatment of neurocysticercosis (NC), a parasitic disease caused by Taenia solium larvae." | 7.69 | Mutation at the HPRT locus in patients with neurocysticercosis treated with praziquantel. ( Cuevas, C; Flisser, A; Madrazo, I; Montero, R; Ostrosky-Wegman, P, 1994) |
| "Standard therapeutic regimens of praziquantel for neurocysticercosis use daily doses of 50 mg/kg for 15-21 days, with prolonged remission being achieved in 60-80% patients." | 7.68 | High-dose praziquantel for neurocysticercosis: efficacy and tolerability. ( Bittencourt, PR; Gorz, AM; Gracia, CM; Mazer, S; Oliveira, TV, 1990) |
| "A preliminary report of praziquantel (PZQ) treatment in 10 patients with cysticercosis in Vietnam is presented in this paper." | 7.67 | Preliminary report of praziquantel treatment of cysticercosis patients in Vietnam. ( Pham, HT; van Knapen, F, 1989) |
| "A retrospective survey involving 25,693 persons was carried out in four provinces and the city of Shanghai, China between December 1981 until May 1982 to document relatively serious side effects of praziquantel used in a mass treatment programme for schistosomiasis japonica." | 7.66 | A retrospective survey on side effects of praziquantel among 25,693 cases of schistosomiasis japonica. ( Chen, MG; Fu, S; Hua, XJ; Wu, HM, 1983) |
| "Report of the observations of 40 patients suffering from neurocysticercosis, submitted to treatment by praziquantel, administered per os." | 7.66 | Administration of praziquantel in neurocysticercosis. ( Livramento, JA; Machado, LR; Nobrega, JP; Spina-França, A, 1982) |
| "Praziquantel has provided new hope." | 5.29 | Praziquantel therapy in neurocysticercosis. ( Agrawal, A; Singhal, KC; Srivastava, A; Srivastava, VK, 1993) |
| "Praziquantel (PZQ) is the drug of choice in the treatment of neurocysticercosis (NC), a parasitic disease caused by Taenia solium larvae." | 3.69 | Mutation at the HPRT locus in patients with neurocysticercosis treated with praziquantel. ( Cuevas, C; Flisser, A; Madrazo, I; Montero, R; Ostrosky-Wegman, P, 1994) |
| "Standard therapeutic regimens of praziquantel for neurocysticercosis use daily doses of 50 mg/kg for 15-21 days, with prolonged remission being achieved in 60-80% patients." | 3.68 | High-dose praziquantel for neurocysticercosis: efficacy and tolerability. ( Bittencourt, PR; Gorz, AM; Gracia, CM; Mazer, S; Oliveira, TV, 1990) |
| "A preliminary report of praziquantel (PZQ) treatment in 10 patients with cysticercosis in Vietnam is presented in this paper." | 3.67 | Preliminary report of praziquantel treatment of cysticercosis patients in Vietnam. ( Pham, HT; van Knapen, F, 1989) |
| "A retrospective survey involving 25,693 persons was carried out in four provinces and the city of Shanghai, China between December 1981 until May 1982 to document relatively serious side effects of praziquantel used in a mass treatment programme for schistosomiasis japonica." | 3.66 | A retrospective survey on side effects of praziquantel among 25,693 cases of schistosomiasis japonica. ( Chen, MG; Fu, S; Hua, XJ; Wu, HM, 1983) |
| "Report of the observations of 40 patients suffering from neurocysticercosis, submitted to treatment by praziquantel, administered per os." | 3.66 | Administration of praziquantel in neurocysticercosis. ( Livramento, JA; Machado, LR; Nobrega, JP; Spina-França, A, 1982) |
| "Treatment with praziquantel associated with cimetidine to increase the drug bioavailability and prednisone to reduce the inflammatory reaction gives good results." | 1.30 | Parenchymatous cerebral neurocysticercosis in a quadriplegic patient. ( Al-Khodairy, AT; Annoni, JM; Uebelhart, D, 1999) |
| "Praziquantel has provided new hope." | 1.29 | Praziquantel therapy in neurocysticercosis. ( Agrawal, A; Singhal, KC; Srivastava, A; Srivastava, VK, 1993) |
| "Neurocysticercosis is an uncommon, and under-recognized condition in Australia." | 1.28 | Neurocysticercosis: an under-recognized cause of neurological problems. ( Collignon, PJ; Crimmins, D; Danta, G; Dwyer, D, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (42.11) | 18.7374 |
| 1990's | 10 (52.63) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferrari, TC | 1 |
| Moreira, PR | 1 |
| Cunha, AS | 1 |
| Chen, MG | 2 |
| Fu, S | 2 |
| Hua, XJ | 2 |
| Wu, HM | 2 |
| Spina-França, A | 1 |
| Nobrega, JP | 1 |
| Livramento, JA | 1 |
| Machado, LR | 1 |
| Montero, R | 1 |
| Flisser, A | 1 |
| Madrazo, I | 1 |
| Cuevas, C | 1 |
| Ostrosky-Wegman, P | 1 |
| Martinez, HR | 1 |
| Rangel-Guerra, R | 1 |
| Arredondo-Estrada, JH | 1 |
| Marfil, A | 1 |
| Onofre, J | 1 |
| del Brutto, OH | 2 |
| Sotelo, J | 2 |
| Roman, GC | 1 |
| Srivastava, VK | 1 |
| Singhal, KC | 1 |
| Srivastava, A | 1 |
| Agrawal, A | 1 |
| Mukherjee, A | 1 |
| Roy, T | 1 |
| Mukherjee, S | 1 |
| Basu, N | 1 |
| Duttamunshi, A | 1 |
| Al-Khodairy, AT | 1 |
| Annoni, JM | 1 |
| Uebelhart, D | 1 |
| Bittencourt, PR | 1 |
| Gracia, CM | 1 |
| Gorz, AM | 1 |
| Mazer, S | 1 |
| Oliveira, TV | 1 |
| Jung, H | 1 |
| Hurtado, M | 1 |
| Medina, MT | 1 |
| Sanchez, M | 1 |
| Crimmins, D | 1 |
| Collignon, PJ | 1 |
| Dwyer, D | 1 |
| Danta, G | 1 |
| Pham, HT | 1 |
| van Knapen, F | 1 |
| Mehndiratta, MM | 1 |
| Gupta, M | 1 |
| Misra, SC | 1 |
| Mansharamani, GG | 1 |
| Alarcón, F | 1 |
| Pérez, Y | 1 |
| Banda, H | 1 |
| Singhal, BS | 1 |
| Sowani, AM | 1 |
1 review available for praziquantel and Nervous System Diseases
| Article | Year |
|---|---|
Therapy for neurocysticercosis: a reappraisal.
Topics: Albendazole; Cysticercosis; Eye Infections, Parasitic; Humans; Nervous System Diseases; Praziquantel | 1993 |
1 trial available for praziquantel and Nervous System Diseases
| Article | Year |
|---|---|
Medical and surgical treatment in neurocysticercosis a magnetic resonance study of 161 cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Brain; Child; Cysticercosis; Female; Humans | 1995 |
17 other studies available for praziquantel and Nervous System Diseases
| Article | Year |
|---|---|
Spinal cord schistosomiasis: a prospective study of 63 cases emphasizing clinical and therapeutic aspects.
Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antiplatyhelmintic Agents; Biopsy; Child; Child, | 2004 |
A retrospective survey on side effects of praziquantel among 25,693 cases of schistosomiasis japonica.
Topics: Adolescent; Adult; Aged; Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Child; Chi | 1983 |
[A retrospective survey on serious side-effects of pyquiton among 25,693 cases of schistosomiasis japonica].
Topics: Cardiovascular Diseases; Chemical and Drug Induced Liver Injury; Female; Humans; Isoquinolines; Male | 1983 |
Administration of praziquantel in neurocysticercosis.
Topics: Adolescent; Adult; Child; Child, Preschool; Cysticercosis; Dexamethasone; Drug Evaluation; Drug Ther | 1982 |
Mutation at the HPRT locus in patients with neurocysticercosis treated with praziquantel.
Topics: Adolescent; Adult; Aged; Cell Division; Cells, Cultured; Cysticercosis; Female; Gene Frequency; Huma | 1994 |
Medical treatment of cysticercosis--effective.
Topics: Albendazole; Cysticercosis; Humans; Nervous System Diseases; Praziquantel | 1995 |
Praziquantel therapy in neurocysticercosis.
Topics: Adolescent; Adult; Brain; Cysticercosis; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Mi | 1993 |
Neurocysticercosis.
Topics: Adolescent; Adult; Albendazole; Antibodies, Helminth; Child; Child, Preschool; Cysticercosis; Enzyme | 1993 |
Parenchymatous cerebral neurocysticercosis in a quadriplegic patient.
Topics: Animals; Anticestodal Agents; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neck; Nervous S | 1999 |
High-dose praziquantel for neurocysticercosis: efficacy and tolerability.
Topics: Adolescent; Adult; Cerebral Ventricles; Cerebrospinal Fluid Shunts; Child; Child, Preschool; Cystice | 1990 |
Dexamethasone increases plasma levels of albendazole.
Topics: Adult; Albendazole; Cysticercosis; Dexamethasone; Drug Therapy, Combination; Female; Humans; Inflamm | 1990 |
Neurocysticercosis: an under-recognized cause of neurological problems.
Topics: Adolescent; Adult; Aged; Australia; Cysticercosis; Diagnosis, Differential; Emigration and Immigrati | 1990 |
Preliminary report of praziquantel treatment of cysticercosis patients in Vietnam.
Topics: Adult; Aged; Cysticercosis; Headache; Humans; Male; Middle Aged; Nervous System Diseases; Praziquant | 1989 |
Praziquantel in neurocysticercosis.
Topics: Cysticercosis; Humans; Nervous System Diseases; Praziquantel | 1989 |
Praziquantel in neurocysticercosis.
Topics: Cysticercosis; Humans; Male; Nervous System Diseases; Praziquantel | 1988 |
Praziquantel and dexamethasone.
Topics: Adult; Aged; Central Nervous System Diseases; Cysticercosis; Dexamethasone; Female; Humans; Male; Mi | 1988 |
Praziquantel in neurocysticercosis.
Topics: Adolescent; Adult; Cysticercosis; Female; Humans; Male; Middle Aged; Nervous System Diseases; Praziq | 1985 |